CRISPR Therapeutics AG (CRSP)
52.59
-0.92
(-1.72%)
USD |
NASDAQ |
Jan 20, 16:00
52.30
-0.29
(-0.55%)
After-Hours: 20:00
CRISPR Therapeutics Free Cash Flow: -303.14M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.337B |
| Intellia Therapeutics, Inc. | -412.63M |
| Beam Therapeutics, Inc. | -352.36M |
| Novartis AG | 17.15B |
| BeOne Medicines Ltd. | 525.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -84.63M |
| Cash from Investing (Quarterly) | -119.23M |
| Cash from Financing (Quarterly) | 296.77M |
| Free Cash Flow Per Share (Quarterly) | -0.9277 |
| Free Cash Flow to Equity (Quarterly) | -80.28M |
| Free Cash Flow to Firm (Quarterly) | -84.71M |
| Free Cash Flow Yield | -6.59% |